These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30153051)

  • 1. Effects of prostaglandin-mediated and cholinergic-mediated miosis on morphology of the ciliary cleft region in dogs.
    Park S; Kang S; Lim J; Park E; Nam T; Jeong S; Seo K
    Am J Vet Res; 2018 Sep; 79(9):980-985. PubMed ID: 30153051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs.
    Sarchahi AA; Abbasi N; Gholipour MA
    Vet Ophthalmol; 2012 Mar; 15 Suppl 1():64-70. PubMed ID: 22050700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats.
    Studer ME; Martin CL; Stiles J
    Am J Vet Res; 2000 Oct; 61(10):1220-4. PubMed ID: 11039551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of travoprost 0.004% compared with latanoprost 0.005% on the intraocular pressure of normal dogs.
    Carvalho AB; Laus JL; Costa VP; Barros PS; Silveira PR
    Vet Ophthalmol; 2006; 9(2):121-5. PubMed ID: 16497237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
    Tofflemire KL; Whitley EM; Allbaugh RA; Ben-Shlomo G; Robinson CC; Overton TL; Thiessen CE; Evans EA; Griggs AN; Adelman SA; Ludwig AL; Jens JK; Ellinwood NM; Peterson CS; Whitley RD
    Am J Vet Res; 2015 Jul; 76(7):625-31. PubMed ID: 26111092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of topical administration of 0.005% latanoprost solution on eyes of clinically normal horses.
    Willis AM; Diehl KA; Hoshaw-Woodard S; Kobayashi I; Vitucci MP; Schmall LM
    Am J Vet Res; 2001 Dec; 62(12):1945-51. PubMed ID: 11763186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of topical latanoprost on anterior segment anatomic relationships in normal dogs.
    Tsai S; Almazan A; Lee SS; Li H; Conforti P; Burke J; Miller PE; Robinson MR
    Vet Ophthalmol; 2013 Sep; 16(5):370-6. PubMed ID: 23227993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Smith LN; Miller PE; Felchle LM
    Am J Vet Res; 2010 Sep; 71(9):1055-61. PubMed ID: 20807145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of topical parasympatholytic drugs on pupil diameter and intraocular pressure in healthy dogs treated with 0.005% latanoprost.
    Kahane N; Raskansky H; Bdolah-Abram T; Ofri R
    Vet Ophthalmol; 2016 Nov; 19(6):464-472. PubMed ID: 26607964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of latanoprost and latanoprostene bunod on intraocular pressure and pupil size in ophthalmologically normal Beagle dogs.
    Desai SJ; Pumphrey SA; Koethe B
    Vet Ophthalmol; 2022 Jul; 25(4):282-290. PubMed ID: 35247289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of preservative-free tafluprost on intraocular pressure, pupil diameter, and anterior segment structures in normal canine eyes.
    Kwak J; Kang S; Lee ER; Park S; Park S; Park E; Lim J; Seo K
    Vet Ophthalmol; 2017 Jan; 20(1):34-39. PubMed ID: 26728904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound biomicroscopic study of the effects of topical latanoprost on the anterior segment and ciliary body thickness in dogs.
    Park S; Kang S; Lee E; Kwak J; Park E; Lim J; Seo K
    Vet Ophthalmol; 2016 Nov; 19(6):498-503. PubMed ID: 26709198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension.
    Kent AR; Vroman DT; Thomas TJ; Hebert RL; Crosson CE
    J Glaucoma; 1999 Aug; 8(4):257-62. PubMed ID: 10464735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of topical ophthalmic administration of 0.005% latanoprost solution on aqueous humor flow rate and intraocular pressure in ophthalmologically normal adult Beagles.
    Fentiman KE; Rankin AJ; Meekins JM; Roush JK
    Am J Vet Res; 2019 May; 80(5):498-504. PubMed ID: 31034278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
    Tofflemire K; Whitley EM; Allbaugh R; Ben-Shlomo G; Griggs A; Strong T; Whitley RD
    Vet Ophthalmol; 2017 Sep; 20(5):398-404. PubMed ID: 27791324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous cats.
    McDonald JE; Kiland JA; Kaufman PL; Bentley E; Ellinwood NM; McLellan GJ
    Vet Ophthalmol; 2016 Jul; 19 Suppl 1(Suppl 1):13-23. PubMed ID: 26183373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs.
    Krohne SG; Gionfriddo J; Morrison EA
    Am J Vet Res; 1998 Apr; 59(4):482-8. PubMed ID: 9563635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
    Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.